Chicago--The American Medical Association has taken a step toward reversing a 2-decades-old policy on the national physician workforce. Since the 1980s, the organization has maintained that the country was threatened with an oversupply of doctors.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.